Chemistry:Zandelisib
From HandWiki
Zandelisib is an investigational new drug that is being evaluated to treat follicular lymphoma.[1] It is a phosphatidylinositol 3 kinase delta inhibitor.[2]
References
- ↑ "Zandelisib - MEI Pharma/Kyowa Kirin". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800038809.
- ↑ "PI3K Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Current Status and Future Perspectives". Cancers 14 (6): 1571. March 2022. doi:10.3390/cancers14061571. PMID 35326722.
 |  |
